Peter D Senter Selected Research

CD27 Ligand

3/2008	Contribution of linker stability to the activities of anticancer immunoconjugates.
2/2006	Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter D Senter Research Topics

Disease

43	Neoplasms (Cancer) 01/2021 - 03/2002
9	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 08/2003
7	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2013 - 08/2003
5	Carcinoma (Carcinomatosis) 06/2009 - 03/2002
5	Renal Cell Carcinoma (Grawitz Tumor) 06/2009 - 01/2006
4	Melanoma (Melanoma, Malignant) 08/2007 - 02/2003
3	Breast Neoplasms (Breast Cancer) 01/2020 - 06/2009
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2010 - 12/2004
2	Hematologic Neoplasms (Hematological Malignancy) 06/2009 - 07/2003
2	Lymphoma (Lymphomas) 03/2008 - 12/2004
1	Cardiotoxicity 12/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Hypoxia (Hypoxemia) 01/2015
1	Ischemia 01/2015
1	Inflammation (Inflammations) 01/2015
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2015
1	Brain Neoplasms (Brain Tumor) 06/2007
1	Prostatic Neoplasms (Prostate Cancer) 04/2006
1	Disease Progression 02/2006
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 08/2003
1	Arthritis (Polyarthritis) 01/2002

Drug/Important Bio-Agent (IBA)

23	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 09/2005
20	Pharmaceutical PreparationsIBA 01/2021 - 07/2003
14	Monoclonal AntibodiesIBA 01/2019 - 07/2003
12	AntigensIBA 01/2019 - 07/2003
9	AntibodiesIBA 01/2021 - 05/2008
8	ProdrugsIBA 03/2006 - 03/2002
6	Brentuximab VedotinIBA 01/2013 - 08/2003
6	monomethyl auristatin EIBA 08/2007 - 07/2003
5	auristatinIBA 01/2017 - 07/2003
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2003
4	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 03/2002
4	Cytotoxins (Cytolysins)IBA 01/2013 - 02/2006
4	EnzymesIBA 05/2005 - 09/2003
3	GlucuronidesIBA 01/2018 - 05/2006
3	Antimitotic AgentsIBA 10/2008 - 01/2006
2	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 01/2004
2	Peptides (Polypeptides)IBA 01/2019 - 07/2003
2	CamptothecinIBA 01/2018 - 06/2009
2	Ado-Trastuzumab EmtansineIBA 08/2010 - 06/2009
2	CD27 LigandIBA 03/2008 - 02/2006
2	CR011-vcMMAEIBA 08/2007 - 02/2006
2	Cathepsin BIBA 04/2006 - 03/2002
2	beta-Lactamases (beta-Lactamase)IBA 09/2003 - 09/2003
2	AcidsIBA 07/2003 - 02/2003
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	NAD (NADH)IBA 12/2018
1	Retinaldehyde (Retinal)IBA 12/2018
1	LactonesIBA 01/2018
1	Ammonium CompoundsIBA 01/2016
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2015
1	E-SelectinIBA 01/2015
1	Hemoglobins (Hemoglobin)IBA 01/2015
1	Cancer VaccinesIBA 04/2013
1	Ki-1 AntigenIBA 01/2013
1	Inotuzumab OzogamicinIBA 08/2010
1	Lewis Y antigenIBA 06/2009
1	Streptonigrin (Nigrin)IBA 05/2009
1	DisulfidesIBA 05/2009
1	Caspase 3 (Caspase-3)IBA 11/2008
1	EphA2 ReceptorIBA 11/2008
1	Phenylalanine (L-Phenylalanine)FDA Link 11/2008
1	Caspase 7IBA 11/2008
1	Sulfides (Thioethers)IBA 03/2008
1	arginyl-glycyl-aspartic acidIBA 09/2007
1	AlbuminsIBA 09/2007
1	Vinblastine (Vinblastine Sulfate)FDA Link 08/2007
1	Interleukin-8 (Interleukin 8)IBA 08/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2007
1	Biological ProductsIBA 06/2007
1	AndrogensIBA 04/2006
1	PSMA ADCIBA 04/2006
1	Cysteine Proteases (Cysteine Protease)IBA 04/2006
1	tumor-associated antigen 72IBA 03/2006
1	CarbohydratesIBA 03/2006
1	EpitopesIBA 03/2006
1	Indicators and Reagents (Reagents)IBA 02/2006
1	Glycoproteins (Glycoprotein)IBA 02/2006
1	Radioisotopes (Radionuclides)IBA 09/2005
1	Rituximab (Mabthera)FDA Link 12/2004
1	Surface Antigens (Surface Antigen)IBA 07/2004
1	phenylenediamine mustardIBA 04/2004
1	cephalosporin mustardIBA 04/2004
1	Cephalosporins (Cephalosporin Antibiotics)IBA 04/2004
1	Mechlorethamine (Nitrogen Mustard)FDA Link 04/2004
1	Single-Domain AntibodiesIBA 04/2004
1	Carcinoembryonic AntigenIBA 04/2004
1	Antineoplastic Agents (Antineoplastics)IBA 09/2003
1	Neoplasm Antigens (Tumor Antigens)IBA 09/2003
1	Single-Chain AntibodiesIBA 09/2003
1	C-MelIBA 09/2003
1	dolastatin 10IBA 07/2003
1	HydrazonesIBA 07/2003
1	DipeptidesIBA 07/2003
1	AmidesIBA 03/2002

Therapy/Procedure

15	Therapeutics 01/2019 - 07/2003
3	Drug Therapy (Chemotherapy) 01/2018 - 06/2007
1	Transcutaneous Electric Nerve Stimulation (TENS) 09/2009